Moreover, in genome-wideassociation studies (GWAS) of Caucasians with schizophrenia or bipolar disorder,neither NRG1 nor ERBB4 have featured among the tophits in the original studies or in subsequent meta-analyses [17], [18]. The gene discussed is NRG1; the disease is schizophrenia.